Trippy Timeline

5 breakthroughs in the psychedelic renaissance

The reputation of psychedelics is shifting from drugs of abuse to medicine.

THEPALMER/Getty Images

Hulton Archive/Getty Images

Since 1970 psychedelics — drugs like psilocybin, MDMA, LSD, and DMT — have been categorized as Schedule I drugs in the United States. By definition, that means they have no accepted medical use.

Before then, some researchers — like psychologist Timothy Leary — advocated for psychedelics. Then their studies came to a grinding halt.

Getty Images


For decades, that meant research on psychedelics was stagnated.

THEPALMER/Getty Images

In recent years, however, the amount of papers published on psychedelics has skyrocketed.

Psychedelics are "re-entering science and society," as a July 2020 perspective article in Frontiers in Psychology puts it.

Click to see the number of papers on LSD, psilocybin, hallucinogens and psychedelics by decade.

The number of papers published between 1990 and 2020, according to a study in "Frontiers in Psychology."

Getty Images/Michael Ciaglo

In the last two years, attitudes towards psychedelics have continued to shift. As recently as November, some Americans have indicated they're ready for a rethink.

Here are five key moments heralding that change. >>


2018: "Breakthrough Therapy" status is achieved

The Washington Post/Getty Images

In October 2018, the Food and Drug Administration granted COMPASS Pathways, a London-based life sciences company, a "breakthrough therapy" designation for its research on psilocybin.


The "breakthrough therapy" designation means the FDA aims to expedite the approval of drugs that treat a serious condition and show promise early on.

Busà Photography/Getty Images

The COMPASS Pathways group gained recognition following a trial on psilocybin and treatment-resistant depression.


Such trials are still continuing.


May 2019: Denver becomes the first city to decriminalize magic mushrooms

Getty Images/ Michael Ciaglo

Voting on a city ordinance during a 2019 election, Denver narrowly voted to decriminalize psilocybin. The decision came down to less than 2,000 votes.

The ordinance aimed to "deprioritize" criminal penalties for possessing personal amounts of psilocybin.

The drug remained illegal in Colorado at large.

Busà Photography/Getty Images


March 2020: A psychedelics company begins public trading for the first time

Yuichiro Chino/Getty Images

Mind Medicine Inc., a company investing in research into LSD and Ibogaine (a psychedelic substance found in plants) began trading on the NEO exchange, a "progressive" stock exchange.

Tony Shi Photography/Getty Images

"MindMed" has since applied to trade on the NASDAQ. However, Compass Pathways, the company granted breakthrough status by the FDA in 2018, got there first.

In September 2020, Compass Pathways became the first psychedelics company to trade on the NASDAQ – a major U.S. stock exchange.


August 2020: Cancer patients in Canada win the right to try psilocybin therapy


In April 2020, four patients in Canada began petitioning the federal government to make an exception to the Canadian Controlled Substances Act, and allow the use of psilocybin during palliative care.

Busà Photography/Getty Images

In August, they won approval, paving the way for more patients to be granted "the right to try."


"It was life-changing, and one of the most beautiful experiences of my life."

November 2020: Oregon becomes the first state to legalize psilocybin-based mental health treatment

EyeWolf/Getty Images

During the 2020 election, Oregon passed a ballot measure that legalized the use of psilocybin in mental health treatment settings for those over 21.

Oregon became the first state to do so.

The measure passed with 56 percent of the vote.

BruceBlock/Getty Images


What's next?

Boogich/Getty Images

More states are considering approaches like Oregon's. California Senator Scott Wiener plans to introduce a bill to decriminalize psilocybin in that state.

In April 2021, a psychedelics hotline will also go live.

Meanwhile, research on psychedelics continues to accumulate...

Catch up on it here.


Thanks for reading,
head home for more!